On Friday, Zai Lab Limited ADR (NASDAQ: ZLAB) opened higher 0.34% from the last session, before settling in for the closing price of $29.14. Price fluctuations for ZLAB have ranged from $16.01 to $39.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 118.89%. Company’s average yearly earnings per share was noted 45.26% at the time writing. With a float of $108.80 million, this company’s outstanding shares have now reached $109.84 million.
The extent of productivity of a business whose workforce counts for 1869 workers is very important to gauge. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.
Zai Lab Limited ADR (ZLAB) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zai Lab Limited ADR is 0.94%, while institutional ownership is 54.71%. The most recent insider transaction that took place on May 09 ’25, was worth 1,481,141. Before that another transaction happened on May 09 ’25, when Company’s Director proposed sale 23,799 for $30.05, making the entire transaction worth $715,086.
Zai Lab Limited ADR (ZLAB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 45.26% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Check out the current performance indicators for Zai Lab Limited ADR (ZLAB). In the past quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach 0.30 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
The latest stats from [Zai Lab Limited ADR, ZLAB] show that its last 5-days average volume of 1.14 million was superior to 1.09 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.94%. Additionally, its Average True Range was 1.83.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 33.98%, which indicates a significant increase from 23.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.77% in the past 14 days, which was lower than the 68.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.10, while its 200-day Moving Average is $27.05. Now, the first resistance to watch is $30.01. This is followed by the second major resistance level at $30.77. The third major resistance level sits at $31.23. If the price goes on to break the first support level at $28.79, it is likely to go to the next support level at $28.33. Assuming the price breaks the second support level, the third support level stands at $27.57.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are currently 110,328K shares outstanding in the company with a market cap of 3.21 billion. Presently, the company’s annual sales total 398,990 K according to its annual income of -257,100 K. Last quarter, the company’s sales amounted to 109,070 K and its income totaled -81,680 K.
